Dow Down0.36% Nasdaq Down0.53%

Enanta Pharmaceuticals, Inc. (ENTA)

-NasdaqGS
40.58 0.72(1.74%)
Analyst EstimatesGet Analyst Estimates for:
Earnings EstCurrent Qtr.
Sep 14
Next Qtr.
Dec 14
Current Year
Sep 14
Next Year
Sep 15
Avg. Estimate-0.334.131.798.98
No. of Analysts6.001.006.006.00
Low Estimate-0.564.131.565.78
High Estimate0.094.132.2817.97
Year Ago EPS-0.25-0.30-0.671.79
Revenue EstCurrent Qtr.
Sep 14
Next Qtr.
Dec 14
Current Year
Sep 14
Next Year
Sep 15
Avg. Estimate3.81M89.68M48.90M250.31M
No. of Analysts6166
Low EstimateNaN89.68M45.10M169.19M
High Estimate16.38M89.68M61.48M386.23M
Year Ago Sales1.35M893.00K32.05M48.90M
Sales Growth (year/est)182.40%9,942.60%52.60%411.90%
Earnings HistorySep 13Dec 13Mar 14Jun 14
EPS Est-0.29-0.290.081.67
EPS Actual-0.25-0.30-0.282.61
Difference0.04-0.01-0.360.94
Surprise %13.80%-3.40%-450.00%56.30%
EPS TrendsCurrent Qtr.
Sep 14
Next Qtr.
Dec 14
Current Year
Sep 14
Next Year
Sep 15
Current Estimate-0.334.131.798.98
7 Days Ago-0.334.131.798.98
30 Days Ago-0.364.131.359.50
60 Days Ago-0.414.130.699.48
90 Days Ago-0.413.690.698.69
EPS RevisionsCurrent Qtr.
Sep 14
Next Qtr.
Dec 14
Current Year
Sep 14
Next Year
Sep 15
Up Last 7 Days0000
Up Last 30 Days2021
Down Last 30 Days0000
Down Last 90 DaysN/AN/AN/AN/A
Growth EstENTAIndustrySectorS&P 500
Current Qtr.-32.00%N/A-76.40%13.40%
Next Qtr.1,476.70%N/A-65.00%23.80%
This Year367.20%N/A45.20%7.70%
Next Year401.70%N/A34.60%13.00%
Past 5 Years (per annum)0.00%N/AN/AN/A
Next 5 Years (per annum)N/A21.77%15.52%10.13%
Price/Earnings (avg. for comparison categories)23.07-0.263.805.75
PEG Ratio (avg. for comparison categories)N/A29.757.890.91
Currency in USD.